📊 MTVA Key Takeaways
Is MetaVia Inc. (MTVA) a Good Investment?
MetaVia is a pre-commercial biotech with minimal revenue ($85K) experiencing severe operational losses ($4M+) and a deteriorating revenue decline (-44.6% YoY). At current cash burn rates of $4.3M quarterly, the company has only 3-4 quarters of runway remaining, indicating imminent financial distress without successful capital raises or product commercialization.
MetaVia’s fundamentals reflect a pre-commercial profile with negligible revenue, severe negative margins, and materially negative operating cash flow. Liquidity is adequate in the near term with meaningful cash and no debt, but the burn rate far exceeds revenue, implying a short runway absent external financing or a step-change in operating traction. YoY loss improvement seems cost-driven rather than revenue quality, leaving sustainability and path to profitability unclear.
MetaVia Inc. Key Strengths (MTVA)
- Working capital position of 2.73x current ratio provides near-term liquidity
- No long-term debt on balance sheet provides flexibility for future financing
- Cash position of $13.7M provides runway for operational expenses in near term
- Solid liquidity with cash covering current liabilities
- Zero long-term debt and no interest burden
- Net loss and EPS improved YoY
MTVA Stock Risks: MetaVia Inc. Investment Risks
- Minimal revenue of $85K indicates no viable product commercialization or market traction
- Operating cash burn of $4.3M per period with limited runway of 3-4 quarters
- Revenue declining sharply at -44.6% YoY suggesting deteriorating business conditions or pilot phase failure
- Operating losses of $4M vastly exceed revenue, indicating business model is not viable
- Negative ROE of -42.1% and ROA of -26.6% destroying shareholder and asset value
- No insider Form 4 activity in 90 days suggests management lacks confidence in company trajectory
- High operating cash burn implying short runway
- Revenue contraction and minimal commercial traction
- Extremely negative margins and returns indicating weak operating leverage
Key Metrics to Watch
- Monthly operating cash burn rate and cash runway remaining
- Revenue trends and new product commercialization milestones
- Operating expenses and cost reduction initiatives
- Capital raise announcements and cash position sustainability
- Operating cash flow (burn rate)
- Cash & equivalents versus projected 12-month burn
MetaVia Inc. (MTVA) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.73x current ratio provides a solid financial cushion.
MTVA Profit Margin, ROE & Profitability Analysis
MTVA vs Healthcare Sector: How MetaVia Inc. Compares
How MetaVia Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is MetaVia Inc. Stock Overvalued? MTVA Valuation Analysis 2026
Based on fundamental analysis, MetaVia Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
MetaVia Inc. Balance Sheet: MTVA Debt, Cash & Liquidity
MTVA Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: MetaVia Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-39.13 indicates the company is currently unprofitable.
MTVA Revenue Growth, EPS Growth & YoY Performance
MetaVia Inc. Dividends, Buybacks & Capital Allocation
MTVA SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for MetaVia Inc. (CIK: 0001638287)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MTVA
What is the AI rating for MTVA?
MetaVia Inc. (MTVA) has a Combined AI Grade of C from Claude (D) and ChatGPT (C) with 85% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are MTVA's key strengths?
Claude: Working capital position of 2.73x current ratio provides near-term liquidity. No long-term debt on balance sheet provides flexibility for future financing. ChatGPT: Solid liquidity with cash covering current liabilities. Zero long-term debt and no interest burden.
What are the risks of investing in MTVA?
Claude: Minimal revenue of $85K indicates no viable product commercialization or market traction. Operating cash burn of $4.3M per period with limited runway of 3-4 quarters. ChatGPT: High operating cash burn implying short runway. Revenue contraction and minimal commercial traction.
What is MTVA's revenue and growth?
MetaVia Inc. reported revenue of $85.0K.
Does MTVA pay dividends?
MetaVia Inc. does not currently pay dividends.
Where can I find MTVA SEC filings?
Official SEC filings for MetaVia Inc. (CIK: 0001638287) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MTVA's EPS?
MetaVia Inc. has a diluted EPS of $-0.79.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is MTVA's fundamental grade?
Based on our AI fundamental analysis in June 2026, MetaVia Inc. has a C grade with 85% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is MTVA stock overvalued or undervalued?
Valuation metrics for MTVA: ROE of -42.1% (sector avg: 15%), net margin of -4,497.6% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is MTVA's AI grade for 2026?
Our dual AI analysis gives MetaVia Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MTVA's free cash flow?
MetaVia Inc.'s operating cash flow is $-4.3M, with capital expenditures of $2.0K. FCF margin is -5,011.8%.
How does MTVA compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -4,497.6% (avg: 12%), ROE -42.1% (avg: 15%), current ratio 2.73 (avg: 2).